RECRUITING

MIVetsCan: Can-Coach Trial (Phase 2)

Talk to us

Conditions

Chronic PainVeteranCannabisCannabidiol

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of the MIVetsCan Can-Coach Trial is to test four coaching sessions to help Veterans with chronic pain use their own cannabis products more effectively to manage pain and related symptoms.

Official Title

MIVetsCan: Cannabis Coaching for Veteran Pain Management Trial (Phase 2)

Quick Facts

Study Start:2024-04-04
Study Completion:2027-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06283862

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * United States Veteran
  2. * Experiencing chronic pain (pain lasting 3 or more months)
  3. * Moderate to severe chronic pain
  4. * Are planning or currently using cannabidiol (CBD) or cannabis products for pain management
  5. * Able to read and speak English sufficiently to allow for informed consent and active participation in the educational intervention sessions
  6. * Willingness to attend all study visits (conducted virtually)
  7. * Willingness to fill out periodic assessments via smartphone to assess symptom status and cannabis use (protocol has more details)
  1. * Inability to provide informed consent (e.g., cognitive impairment, unable to sufficiently communicate in English)
  2. * Participant states participant is pregnant
  3. * Current diagnosis or past history of a psychotic disorder (schizophrenia spectrum, except substance/medication -induced or due to another condition)
  4. * Current diagnosis or past history of bipolar disorder
  5. * Unable to attend study visits
  6. * Risk for imminent harm - Suicidal ideation or wish to die as assessed with the Positive and Negative Suicide Ideation (PANSI) questionnaire and further risk assessment by study team members
  7. * Any impairment, activity, behavior, or situation that in the judgment of the study team would prevent satisfactory completion of the study protocol

Contacts and Locations

Study Contact

Vivian Kurtz
CONTACT
734-998-7156
vkurtz@umich.edu

Principal Investigator

Kevin Boehnke, PhD
STUDY_CHAIR
University of Michigan

Study Locations (Sites)

University of Michigan
Ann Arbor, Michigan, 48105
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Kevin Boehnke, PhD, STUDY_CHAIR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-04
Study Completion Date2027-02

Study Record Updates

Study Start Date2024-04-04
Study Completion Date2027-02

Terms related to this study

Keywords Provided by Researchers

  • Veteran
  • Cannabis
  • Cannabidiol

Additional Relevant MeSH Terms

  • Chronic Pain